trans-chlordane | 5103-74-2

• 物质功能分类: 化学农药原药 - 杀虫剂 - 有机氯杀虫剂
• 分子结构分类: 有机化合物 - 有机卤素化合物 - 乙烯基卤化物
• 英文名称: trans-chlordane
• 英文别名: (1R,2R,3S,4S,6R,7S)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene
• CAS: 5103-74-2
• 化学式: C₁₀H₆Cl₈
• 分子量: 409.782
• InChiKey: BIWJNBZANLAXMG-OESJLNMISA-N

物化性质

• 熔点：
  106°C (estimate)
• 沸点：
  492.46°C (rough estimate)
• 密度：
  1.80
• 闪点：
  -18 °C
• 溶解度：
  与脂肪族和芳香族溶剂混溶(USEPA,1985)
• 蒸汽压力：
  2.05e-05 mmHg
• 亨利常数：
  2.93e-04 atm-m3/mole

计算性质

• 辛醇/水分配系数(LogP)：
  4.9
• 重原子数：
  18
• 可旋转键数：
  0
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.8
• 拓扑面积：
  0
• 氢给体数：
  0
• 氢受体数：
  0

ADMET

毒理性

• 副作用

职业性肝毒素 - 第二类肝毒素：在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒案例。 其他毒物 - 有机氯 国际癌症研究机构致癌物 - 第3类：这些化学物质无法被国际癌症研究机构分类。

Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation. Other Poison - Organochlorine IARC Carcinogen - Class 3: Chemicals are not classifiable by the International Agency for Research on Cancer.

来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

安全信息

• 危险等级：
  6.1(b)
• 危险品标志：
  F,N,Xn
• 安全说明：
  S16,S25,S26,S29,S33,S36/37,S45,S60,S61,S62,S9
• 危险类别码：
  R11,R67,R22,R51/53,R48/20,R65,R40,R48,R62,R36/37/38,R38,R50/53,R20/21/22
• WGK Germany：
  3
• RTECS号：
  PC0365000
• 包装等级：
  III
• 危险类别：
  6.1(b)

制备方法与用途

类别：农药
毒性分级：高毒
急性毒性：口服-大鼠 LD50: 1100 毫克/公斤；口服-小鼠 LD50: 275 毫克/公斤
可燃性危险特性：热分解排出有毒氯化物和烟雾
储运特性：库房应低温、通风干燥，并与食品原料分开存放
灭火剂：水、二氧化碳、泡沫、干粉

文献信息

• Guest-compound-enveloping polymer-metal-complex crystal, method for producing same, method for preparing crystal structure analysis sample, and method for determining molecular structure of organic compound
  申请人：JAPAN SCIENCE AND TECHNOLOGY AGENCY

  公开号：US10190952B2

  公开（公告）日：2019-01-29

  The present invention is: a guest-compound-enveloping polymer-metal-complex crystal characterized by at least one selected from an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenated hydrocarbon, and a nitrile being enveloped as a guest compound (A) in the minute pores or the like of a polymer-metal complex that contains a metal ion as a central metal and a ligand having at least two ligating sites, has a 3D network structure formed by the ligand being ligated to the metal ion, and has the minute pores or the like regularly arranged three-dimensionally within the 3D network structure, the amount of the guest compound (A) present within the minute pores or the like being at least 60 mol % of all the guest compounds enveloped in the minute pores or the like; a method for producing the guest-compound-enveloping polymer-metal-complex crystal; a method for preparing a crystal structure analysis sample using the crystal; and a method for determining the molecular structure of an organic compound using the sample obtained by said method.

  本发明是：一种客体-化合物-包络聚合物-金属-配合物晶体，其特征在于，至少选择了一种烷基烃、脂环烃、醚、酯、芳香烃、卤代烃和腈中的一种作为包络的客体化合物（A），该化合物存在于包含金属离子作为中心金属和至少具有两个配位位点的配体的聚合物-金属-配合物的微孔或类似中，具有由配体与金属离子配位形成的3D网络结构，并且在该3D网络结构内三维地规则排列着微孔或类似，存在于微孔或类似中的客体化合物（A）的量至少占所有包络在微孔或类似中的客体化合物的60摩尔％；一种制备客体-化合物-包络聚合物-金属-配合物晶体的方法；一种利用该晶体制备晶体结构分析样品的方法；以及一种利用通过所述方法获得的样品确定有机化合物的分子结构的方法。
• FMO3 inhibitors for treating pain
  申请人：Akron Molecules GmbH

  公开号：EP2674161A1

  公开（公告）日：2013-12-18

  The present invention relates to new therapies to treat pain and related diseases, as well as pharmaceutical compounds for use in said therapies.

  本发明涉及治疗疼痛和相关疾病的新疗法，以及用于上述疗法的药物化合物。
• Label-free method for the detection of analytes
  申请人：Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.

  公开号：EP2752664A1

  公开（公告）日：2014-07-09

  The present invention relates to method for the detection and/or characterization of an analyte based on determining and preferably optical determining the alteration of mechanical deformation of hydrogel particles and kits suitable for this method.

  本发明涉及基于测定（最好是光学测定）水凝胶颗粒机械变形的变化来检测和/或表征分析物的方法，以及适用于该方法的试剂盒。
• GUEST-COMPOUND-ENVELOPING POLYMER-METAL-COMPLEX CRYSTAL, METHOD FOR PRODUCING SAME, METHOD FOR PREPARING CRYSTAL STRUCTURE ANALYSIS SAMPLE, AND METHOD FOR DETERMINING MOLECULAR STRUCTURE OF ORGANIC COMPOUND
  申请人：Japan Science and Technology Agency

  公开号：EP2894242A1

  公开（公告）日：2015-07-15

  The present invention is: a guest-compound-enveloping polymer-metal-complex crystal characterized by at least one selected from an aliphatic hydrocarbon, an alicyclic hydrocarbon, an ether, an ester, an aromatic hydrocarbon, a halogenated hydrocarbon, and a nitrile being enveloped as a guest compound (A) in the minute pores or the like of a polymer-metal complex that contains a metal ion as a central metal and a ligand having at least two ligating sites, has a 3D network structure formed by the ligand being ligated to the metal ion, and has the minute pores or the like regularly arranged three-dimensionally within the 3D network structure, the amount of the guest compound (A) present within the minute pores or the like being at least 60 mol% of all the guest compounds enveloped in the minute pores or the like; a method for producing the guest-compound-enveloping polymer-metal-complex crystal; a method for preparing a crystal structure analysis sample using the crystal; and a method for determining the molecular structure of an organic compound using the sample obtained by said method.

  本发明是一种客体化合物包络聚合物-金属络合物晶体，其特征在于至少一种选自脂肪族烃、脂环族烃、醚、酯、芳香族烃、卤代烃和腈的客体化合物(A)作为客体化合物包络在聚合物-金属络合物的微孔或类似物中，该聚合物-金属络合物包含作为中心金属的金属离子和具有至少两个配位位点的配体、具有由配体与金属离子连接形成的三维网络结构，并且微孔等在三维网络结构中呈规则的三维排列，存在于微孔等中的客体化合物（A）的量至少为包覆在微孔等中的所有客体化合物的 60 摩尔%；一种生产客体化合物包覆聚合物-金属-复合物晶体的方法；一种使用该晶体制备晶体结构分析样品的方法；以及一种使用上述方法获得的样品确定有机化合物分子结构的方法。
• Membrane-based processes for selectively fractionating essential oils
  申请人：Evonik Membrane Extraction Technology Ltd.

  公开号：US10202562B2

  公开（公告）日：2019-02-12

  The present disclosure in general relates to a process for (1) reducing impurities, i.e. undesirable natural components such as waxes and undesirable synthetic materials such as agrochemicals and other environmental pollutants, or (2) fractionation of natural components present in an essential oil using at least one selective membrane.

  本公开内容总体上涉及一种工艺，用于 (1) 减少杂质，即减少蜡等不良天然成分和农用化学品及其他环境污染物等不良合成材料，或 (2) 使用至少一种选择性膜对精油中的天然成分进行分馏。